KK
LGND icon

KLP Kapitalforvaltning’s Ligand Pharmaceuticals LGND Stock Holding History

KLP Kapitalforvaltning’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.49M Hold
4,700
– – ﹤0.01% 928
2026
Q1 		$938K Buy
4,700
+500
+12% +$98.9K ﹤0.01% 1062
2025
Q4 		$794K Buy
4,200
+300
+8% +$57.6K ﹤0.01% 1160
2025
Q3 		$691K Hold
3,900
– – ﹤0.01% 1242
2025
Q2 		$443K Hold
3,900
– – ﹤0.01% 1423
2025
Q1 		$410K Hold
3,900
– – ﹤0.01% 1412
2024
Q4 		$418K Buy
+3,900
New +$441K ﹤0.01% 1478

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

KLP Kapitalforvaltning's LGND Position: Q2 2026 in Review

KLP Kapitalforvaltning held its Ligand Pharmaceuticals (LGND) position steady in Q2 2026 at 4,700 shares worth $1.49M. The position accounts for ﹤0.01% of the portfolio, ranked #928.

KLP Kapitalforvaltning first reported a position in LGND in Q4 2024 and has held it in 7 quarters since. 414 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • KLP Kapitalforvaltning held 4,700 shares of Ligand Pharmaceuticals worth $1.49M as of Q2 2026.
  • KLP Kapitalforvaltning left its Ligand Pharmaceuticals share count unchanged in Q2 2026.
  • Ligand Pharmaceuticals made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #928 holding.
  • KLP Kapitalforvaltning first reported a position in Ligand Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 414 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.